Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

VYGR

VYGR News

Newswire

02:46

HC Wainwright & Co. Keeps Voyager Therapeutics at Buy Rating with 275.12% Upside Potential

13:46

HC Wainwright Maintains Buy Rating on Voyager Therapeutics with $25 PT.

08:11

Transition Bio, Voyager Therapeutics Partner for ALS, FTD Drug Discovery

13:05

Voyager Technologies' 15min chart indicates MACD and KDJ Death Cross signals.

16:36

Voyager Therapeutics CFO Nathan Jorgensen Sells 7666 Shares at $4.78/Share

View More

About VYGR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More